FDA Designates Cannabis-Derived Treatment for Chronic Back Pain as Breakthrough Therapy

The FDA has awarded Breakthrough Therapy Designation to VER-01, an experimental cannabis-derived medication for chronic low back pain. This decision follows promising results from two Phase 3 trials, which indicated notable pain relief and improved patient tolerability. If ultimately approved, VER-01 could introduce a new non-opioid option for pain management in the United States.